The Role of Fibrocytes in Sickle Cell Lung Disease
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Interstitial lung disease is a frequent complication in sickle cell disease and is characterized by vascular remodeling and interstitial fibrosis. Bone marrow-derived fibrocytes have been shown to contribute to the pathogenesis of other interstitial lung diseases. The goal of this study was to define the contribution of fibrocytes to the pathogenesis of sickle cell lung disease. METHODOLOGY/PRINCIPAL FINDINGS: Fibrocytes were quantified and characterized in subjects with sickle cell disease or healthy controls, and in a model of sickle cell disease, the NY1DD mouse. The role of the chemokine ligand CXCL12 in trafficking of fibrocytes and phenotype of lung disease was examined in the animal model. We found elevated concentration of activated fibrocytes in the peripheral blood of subjects with sickle cell disease, which increased further during vaso-occlusive crises. There was a similar elevations in the numbers and activation phenotype of fibrocytes in the bone marrow, blood, and lungs of the NY1DD mouse, both at baseline and under conditions of hypoxia/re-oxygenation. In both subjects with sickle cell disease and the mouse model, fibrocytes expressed a hierarchy of chemokine receptors, with CXCR4 expressed on most fibrocytes, and CCR2 and CCR7 expressed on a smaller subset of cells. Depletion of the CXCR4 ligand, CXCL12, in the mouse model resulted in a marked reduction of fibrocyte trafficking into the lungs, reduced lung collagen content and improved lung compliance and histology. CONCLUSIONS: These data support the notion that activated fibrocytes play a significant role in the pathogenesis of sickle cell lung disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“studies have found that elevated baseline levels of circulating fibrocytes, a type of mesenchymal, bone marrow–derived cell, are responsible for lung fibrogenesis in SCD mouse models (223).”
From Pathophysiology of Sickle Cell Disease (2019) · cites this paper as [223]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pain in Sickle Cell Disease: Rates and Risk Factors
Platt, O. S., Thorington, B. D., Brambilla, D. J., Milner, P. F., Rosse, W. F., Vichinsky, E., & Kinney, T. R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199107043250103 · Cited by 1,546 · cited 12×
“These data are consistent with NY1DD mice and support the notion that disease exacerbations (i.e., VOC) significantly contribute to the development of end organ disease.”
BackgroundInfluentialPulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease
Gladwin, M. T., Sachdev, V., Jison, M. L., Shizukuda, Y., Plehn, J. F., Minter, K., Brown, B., Coles, W. A., Nichols, J. S., Ernst, I., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035477 · Cited by 1,325
Circulating Fibrocytes Define a New Leukocyte Subpopulation That Mediates Tissue Repair
Bucala, R., Spiegel, L. A., Chesney, J., Hogan, M., & Cerami, A. (1994) · Molecular Medicine · doi:10.1007/bf03403533 · Cited by 1,308
Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis
Phillips, R. J., Burdick, M. D., Hong, K., Lutz, M. A., Murray, L. A., Xue, Y. Y., Belperio, J. A., Keane, M. P., & Strieter, R. M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420997 · Cited by 1,079
Self-citationOutcome of Sickle Cell Anemia: A 4-Decade Observational Study of 1056 Patients
Powars, D. R., Chan, L. S., Hiti, A., Ramicone, E., & Johnson, C. (2005) · Medicine · doi:10.1097/01.md.0000189089.45003.52 · Cited by 558
Sickle Hemoglobin (Hb S) Allele and Sickle Cell Disease: A HuGE Review
Ashley-Koch, A., Yang, Q., & Olney, R. S. (2000) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010288 · Cited by 528 · cited 1×
“Sickle cell disease (SCD) is the most common monogenic inherited disorder in African-Americans [1].”
BackgroundCirculating Fibrocytes Are an Indicator of Poor Prognosis in Idiopathic Pulmonary Fibrosis
Moeller, A., Gilpin, S. E., Ask, K., Cox, G., Cook, D., Gauldie, J., Margetts, P. J., Farkas, L., Dobranowski, J., Boylan, C., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200810-1534oc · Cited by 513
Self-citationPulmonary Complications of Sickle Cell Disease
Gladwin, M. T., & Vichinsky, E. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0804411 · Cited by 470
Phillips, R. J., Burdick, M. D., Lutz, M., Belperio, J. A., Keane, M. P., & Strieter, R. M. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200301-071oc · Cited by 455
Self-citationCCR2-Mediated Recruitment of Fibrocytes to the Alveolar Space after Fibrotic Injury
Moore, B. B., Kolodsick, J. E., Thannickal, V. J., Cooke, K., Moore, T. A., Hogaboam, C., Wilke, C. A., & Toews, G. B. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62289-4 · Cited by 441
Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice
Kaul, D. K., & Hebbel, R. P. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9225 · Cited by 417
Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis
Andersson-Sjöland, A., de Alba, C. G., Nihlberg, K., Becerril, C., Ramírez, R., Pardo, A., Westergren-Thorsson, G., & Selman, M. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.02.012 · Cited by 360
Fukuda, Y., Ishizaki, M., Masuda, Y., Kimura, G., Kawanami, O., & Masugi, Y. (1987) · PubMed · Cited by 339
Sickle cell chronic lung disease: prior morbidity and the risk of pulmonary failure.
Powars, D., WEIDMAN, J. A., Odom‐Maryon, T., Niland, J. C., & Johnson, C. M. (1988) · PubMed · Cited by 329
Phillips, R. J., Mestas, J., Gharaee-Kermani, M., Burdick, M. D., Sica, A., Belperio, J. A., Keane, M. P., & Strieter, R. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500963200 · Cited by 323
Self-citationPulmonary hypertension in patients with sickle cell disease: a longitudinal study
Ataga, K. I., Moore, C. G., Jones, S., Olajide, O., Strayhorn, D., Hinderliter, A., & Orringer, E. P. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06110.x · Cited by 298 · cited 1×
“More recently, several large studies have demonstrated an increased risk of death associated with pulmonary hypertension in adults with SCD [5,38,39].”
BackgroundSickle Cell Chronic Lung Disease: Prior Morbidity and the Risk of Pulmonary Failure
POWARS, D., WEIDMAN, J. A., ODOM-MARYON, T., NILAND, J. C., & JOHNSON, C. (1988) · Medicine · doi:10.1097/00005792-198801000-00005 · Cited by 282
The role of CXC chemokines in pulmonary fibrosis
Strieter, R. M., Gomperts, B. N., & Keane, M. P. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30562 · Cited by 273
Self-citationAnthi, A., Machado, R. F., Jison, M. L., Taveira-DaSilva, A. M., Rubin, L. J., Hunter, L., Hunter, C. J., Coles, W., Nichols, J., Avila, N. A., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200610-1498oc · Cited by 270
Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease
Mehrad, B., Burdick, M. D., Zisman, D. A., Keane, M. P., Belperio, J. A., & Strieter, R. M. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.11.149 · Cited by 255
Self-citationDe Castro, L. M., Jonassaint, J. C., Graham, F. L., Ashley‐Koch, A., & Telen, M. J. (2008) · American Journal of Hematology · doi:10.1002/ajh.21058 · Cited by 243
Fibrocytes: a unique cell population implicated in wound healing
Metz, C. N. (2003) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/s00018-003-2328-0 · Cited by 235
Reperfusion injury pathophysiology in sickle transgenic mice
Osarogiagbon, U. R., Choong, S., Belcher, J. D., Vercellotti, G. M., Paller, M. S., & Hebbel, R. P. (2000) · Blood · doi:10.1182/blood.v96.1.314 · Cited by 233
Keane, M. P., Belperio, J. A., Arenberg, D. A., Burdick, M. D., Xu, Z., Xue, Y., & Strieter, R. M. (1999) · PubMed · Cited by 232
Self-citationReduction of Bleomycin-Induced Pulmonary Fibrosis by Serum Amyloid P
Pilling, D., Roife, D., Wang, M., Ronkainen, S. D., Crawford, J. R., Travis, E. L., & Gomer, R. H. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.4035 · Cited by 230 · cited 1×
“Fibrocytes are important in mediating pulmonary fibrosis in murine models of lung injury [7,13,19,20,21,22] and are elevated in the blood and lungs of patients with idiopathic pulmonary fibrosis (IPF) [23,24,25].”
BackgroundHong, K. M., Belperio, J. A., Keane, M. P., Burdick, M. D., & Strieter, R. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703597200 · Cited by 225
Self-citationKeane, M. P., Belperio, J. A., Arenberg, D. A., Burdick, M. D., Xu, Z. J., Xue, Y. Y., & Strieter, R. M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.10.5686 · Cited by 212
Self-citationAbnormal Pulmonary Function in Adults with Sickle Cell Anemia
Klings, E. S., Wyszynski, D. F., Nolan, V. G., & Steinberg, M. H. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200601-125oc · Cited by 206
Strieter, R. M., Keeley, E. C., Hughes, M. A., Burdick, M. D., & Mehrad, B. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0309132 · Cited by 199
Self-citationBaran, C. P., Opalek, J. M., McMaken, S., Newland, C. A., O'Brien, J. M., Hunter, M. G., Bringardner, B. D., Monick, M. M., Brigstock, D. R., Stromberg, P. C., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200609-1279oc · Cited by 196
Fibrocyte CXCR4 regulation as a therapeutic target in pulmonary fibrosis
Mehrad, B., Burdick, M. D., & Strieter, R. M. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.02.020 · Cited by 175
Self-citationCXCL11 Attenuates Bleomycin-induced Pulmonary Fibrosis via Inhibition of Vascular Remodeling
Burdick, M. D., Murray, L. A., Keane, M. P., Xue, Y. Y., Zisman, D. A., Belperio, J. A., & Strieter, R. M. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200409-1164oc · Cited by 164
Self-citationWallace, K. L., Marshall, M. A., Ramos, S. I., Lannigan, J. A., Field, J. J., Strieter, R. M., & Linden, J. (2009) · Blood · doi:10.1182/blood-2009-02-205492 · Cited by 155
Self-citationGomperts, B. N., & Strieter, R. M. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0906587 · Cited by 142
Self-citationThe acute respiratory distress syndrome: fibrosis in the fast lane
Marshall, R. P., Bellingan, G. J., & Laurent, G. J. (1998) · Thorax · doi:10.1136/thx.53.10.815 · Cited by 138
Strieter, R. M. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200710-160dr · Cited by 133
Self-citationBlease, K., Schuh, J. M., Jakubzick, C., Lukacs, N. W., Kunkel, S. L., Joshi, B. H., Puri, R. K., Kaplan, M. H., & Hogaboam, C. M. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64867-5 · Cited by 116
Exacerbation of Established Pulmonary Fibrosis in a Murine Model by Gammaherpesvirus
McMillan, T. R., Moore, B. B., Weinberg, J. B., Vannella, K. M., Fields, W. B., Christensen, P. J., van Dyk, L. F., & Toews, G. B. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200708-1184oc · Cited by 111
Fibrocytes: Bringing new insights into mechanisms of inflammation and fibrosis
Keeley, E. C., Mehrad, B., & Strieter, R. M. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.10.014 · Cited by 106
Self-citationMaeda, A., Hiyama, K., Yamakido, H., Ishioka, S., & Yamakido, M. (1996) · CHEST Journal · doi:10.1378/chest.109.3.780 · Cited by 100
The role of fibrocytes in fibrotic diseases of the lungs and heart
Keeley, E. C., Mehrad, B., & Strieter, R. M. (2011) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-4-2 · Cited by 74
Self-citationvan Deventer, H. W., Wu, Q., Bergstralh, D. T., Davis, B. K., O’Connor, B. P., Ting, J. P. ‐., & Serody, J. S. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070732 · Cited by 63
Mechanisms of Pulmonary Fibrosis
Strieter, R. M. (2001) · CHEST Journal · doi:10.1378/chest.120.1_suppl.s77-a · Cited by 52
Self-citation
Cited by
Pathophysiology of Sickle Cell Disease
Sundd, P., Gladwin, M. T., & Novelli, E. M. (2019) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012838 · Cited by 813
Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells
Gilbane, A. J., Denton, C. P., & Holmes, A. M. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4230 · Cited by 196
CXCL12/CXCR4: An amazing challenge and opportunity in the fight against fibrosis
Wu, X., Lu, Q., Zhao, H., Lei, W., Liu, Y., Xu, X., Li, J., Yang, Z., Wang, D., Zhang, Y., et al. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101809 · Cited by 119
Weiss, D. J. (2013) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201304-090aw · Cited by 62
The role of circulating fibrocytes in inflammation and autoimmunity
Galligan, C. L., & Fish, E. N. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0712365 · Cited by 68
Metadata
- Authors
- Field, J. J., Burdick, M. D., DeBaun, M. R., Strieter, B. A., Liu, L., Mehrad, B., Rose, C. E., Linden, J., & Strieter, R. M.
- Affiliations
- Versiti Blood Center of Wisconsin (US)
- University of Virginia (US)
- Vanderbilt University (US)
- La Jolla Institute for Immunology (US)
- Corresponding author
- Strieter, Robert M.
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-03-19
- Volume
- 7
- Issue
- 3
- Pages
- e33702
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3307761
- OpenAlex
- W2001774986
- Cited by
- 23
- References
- 43
- Citations by year
- 2025: 1 · 2022: 1 · 2020: 3 · 2019: 1 · 2018: 1 · 2017: 4 · 2016: 1 · 2015: 2 · 2014: 3 · 2013: 4 · 2012: 2
- FWCI
- 1.68
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health (5f32hl008710-03, UL1TR000448)
- National Heart, Lung, and Blood Institute (R01HL098526, HL073848, HL079937, HL098526, R01HL095704, R01HL079937, HL066027, R01HL098329, HL098329, R01HL066027, R01HL073848, HL08710)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Keywords
- fibrocytes, interstitial lung disease, CXCL12, CXCR4, chemokine receptors, vaso-occlusive crisis, pulmonary fibrosis, lung collagen, lung compliance
- MeSH terms
- Adult, Anemia, Sickle Cell, Animals, Cell Movement, Collagen, Female, Humans, Male, Middle Aged, Pulmonary Fibrosis, Lung Diseases, Interstitial, Receptors, Chemokine, Mice, Chemokine CXCL12
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.